News
Keep up to date with our news, press releases, and recent announcements.
Press
News
March 09, 2021
WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City
Kansas City joins Hawaii Medical Services Association, BCBS South Carolina, and Avalon in considering WATS3D a covered benefit
Press
News
January 27, 2021
WATS3D Now Considered Medically Necessary by BlueCross BlueShield of South Carolina
SUFFERN, NY, Jan. 26, 2021 (GLOBE NEWSWIRE)) – WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and …
Press
News
December 15, 2020
CDx Diagnostics Awarded Federal Supply Schedule Contract
Veterans now have access to WATS3D life-saving technology in the VA and community settings SUFFERN, NY (December 15, 2020) – CDx Diagnostics has been …
Press
August 25, 2020
Study Confirms WATS3D as Cost-Effective Adjunct to Seattle Protocol
The addition of WATS3D to the screening process for BE resulted in approximately 3 fewer cancers and 3 fewer cancer deaths per 1,000 people screened
Press
August 11, 2020
CDx Diagnostics Announces Contract with Hawaii Medical Services Association
WATS3D diagnostic platform for screening and surveillance of Barrett’s esophagus now available to 800,000 members
Press
June 16, 2020
SAGES TAVAC Analysis Indicates WATS3D is a Safe and Effective Diagnostic Technique for Barrett’s Esophagus
SUFFERN, NY (June 16, 2020) – WATS3D, an AI-powered diagnostic platform used to identify precancerous cells in the esophagus, has been deemed as a …
Press
April 02, 2020
CDx Diagnostics Announces Contract with Blue Cross Blue Shield of Massachusetts for WATS3D Biopsy
- Newly issued coverage statement on diagnostic platform for screening and surveillance of Barrett’s esophagus - SUFFERN, N.Y., April 02, 2020 (GLOBE …
Press
September 04, 2019
American Society for Gastrointestinal Endoscopy Includes WATS3D in Its New Practice Guideline for the Screening and Surveillance of Barrett’s Esophagus
SUFFERN, N.Y., (GLOBE NEWSWIRE), September 4, 2019 — CDx Diagnostics®, developer of the WATS3D diagnostic platform for the screening and surveillance …
Press
August 08, 2017
WATS3D Shown to be over 4X More Effective in Detecting High-Grade Dysplasia and Esophageal Adenocarcinoma
New results published in Gastrointestinal Endoscopy
Get the latest posts in your email.
